Exploring the cause of oseltamivir resistance against mutant H274Y neuraminidase by molecular simulation approach

Applied Biochemistry and Biotechnology

Volumn 167, Issue 2, 2012, Pages 237-249

  Karthick, V ^a   Shanthi, V ^a   Rajasekaran, R ^a   Ramanathan, K ^a  

^a VIT UNIVERSITY   (India)

Author keywords

Molecular docking; Molecular dynamic simulation; Neuraminidase; Normal mode analysis; Oseltamivir resistance

Indexed keywords

ANTI-VIRAL DRUGS; BINDING AFFINITIES; COLLECTIVE MOTIONS; FLU VIRUS; H-BONDS; HIGH FLEXIBILITY; MOLECULAR DOCKING; MOLECULAR DYNAMICS SIMULATIONS; MOLECULAR SIMULATIONS; NEURAMINIDASE; NORMAL MODE ANALYSIS; OSELTAMIVIR; SURFACE GLYCOPROTEINS; TAMIFLU; WILD TYPES;

BINDING ENERGY; COMPUTER SIMULATION; MOLECULAR DYNAMICS; MOLECULAR MODELING;

VIRUSES;

OSELTAMIVIR; VIRUS SIALIDASE;

ANTIVIRAL RESISTANCE; ARTICLE; ENZYME ANALYSIS; GENE MUTATION; HYDROGEN BOND; INFLUENZA A (H1N1); MOLECULAR DOCKING; MOLECULAR DYNAMICS; NONHUMAN; VIRUS STRAIN;

AMINO ACID SUBSTITUTION; ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; ENZYME INHIBITORS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MOLECULAR DYNAMICS SIMULATION; MUTATION, MISSENSE; NEURAMINIDASE; OSELTAMIVIR; VIRAL PROTEINS;

EID: 84861481032     PISSN: 02732289     EISSN: 15590291     Source Type: Journal    
DOI: 10.1007/s12010-012-9687-7     Document Type: Article

References (39)

1. Mukhtar, M. M., Rasool, S. T., Song, D., Zhu, C., Hao, Q., Zhu, Y., & Wu, J. (2007). Journal of General Virology, 88, 3094-3099.
2. Shirvan, A. N.,Moradi, M., Aminian,M.,&Madani, R. J. (2007). Vetenary and Animal Science, 31, 219-223.
3. Takeda, M., Leser, G. P., Russell, C. J., & Lamb, R. A. (2003). Proceedings of the National Academy of Sciences, 100, 14610-14617.
4. McKimm-Breschkin, J. L. (2000). Antiviral Research, 47, 1-17.
5. Du, Q. S., Wang, S. Q., & Chou, K. C. (2007). Biophysica Research Communication, 354, 634-640.
6. Von Itzstein, M., Wu, W. Y., Kok, G. B., Pegg, M. S., Dyason, J. C., Jin, B., Van Phan, T., Smythe, M. L., White, H. F., & Oliver, S. W. (1993). Nature, 363, 418-423.
7. Kim, C. U., Lew, W., Williams, M. A., Liu, H., Zhang, L., Swaminathan, S., Bischofberger, N., Chen, M. S., Mendel, D. B., & Tai, C. Y. (1997). Journal of the American Chemical Society, 119, 681-690.
8. Gubareva, L. V., Kaiser, L., & Hayden, F. G. (2000). Lancet, 355, 827-835.
9. Bucher, D. J., & Kilbourne, E. D. (1972). Journal of Virology, 10, 60-66.
10. Baum, S. G. (2009). Clinical Infectious Diseases, 49, 1836-1837.
11. Centers for Disease Control & Prevention (CDC). (2008). MMWR Morb Mortal Wkly Rep, 57, 1329-1332.
12. Gubareva, L. V. (2004). Virus Research, 103, 199-203.
13. Lander, G. C., Evilevitch, A., Jeembaeva, M., Potter, C. S., Carragher, B., & Johnson, J. E. (2008). Structure, 16, 1399-1406.
14. Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., Shindyalov, I. N., &Bourne, P. E. (2000). Nucleic Acids Research, 28, 235-242.
15. Russell, R. J., Haire, L. F., Stevens, D. J., Collins, P. J., Lin, Y. P., Blackburn, G. M., Hay, A. J., Gamblin, S. J., & Skehel, J. J. (2006). Nature, 443, 45-49.
16. Collins, P. J., Haire, L. F., Lin, Y. P., Liu, J., Russell, R. J., Walker, P. A., Skehel, J. J., Martin, S. R., Hay, A. J., & Gamblin, S. J. (2008). Nature, 453, 1258-1261.
17. Feldman, J., Snyder, K. A., Ticoll, A., Pintilie, G., & Hogue, C. W. (2006). FEBS Letters, 580, 1649-1653.
18. Gasteiger, J., Rudolph, C., & Sadowski, J. (1990). Tetrahedron. Compututer, Method, 3, 537-547.
19. Lopez, G., Valencia, A., & Tress, M. L. (2007). Nucleic Acids Research, 35, 573-577.
20. Yuan, Z., Bailey, T. L., & Teasdale, R. D. (2005). Proteins, 58, 905-912.
21. Ringe, D., & Petsko, G. A. (1986). Methods in Enzymology, 131, 389-433.
22. Parthasarathy, S., & Murthy, M. (2000). r. Protein Engineering, 13, 9-13.
23. Carlson, H. A., & McCammon, J. A. (2000). Molecular Pharmacology, 57, 213-218.
24. Hinkle, A., & Tobacman, L. S. (2003). Journal of Biological Chemistry, 278, 506-513.
25. Rajasekaran, R., George Priya Doss, C., Sudandiradoss, C., Ramanathan, K., Purohit, R., & Sethumadhavan, R. (2008). Comptes Rendus Biologies, 331, 409-417.
26. Suhre, K., & Sanejouand, Y. H. (2004). Nucleic Acids Research, 32, 610-614.
27. Thompson M. A. (2004). ArgusLab 4.0.1. Planaria Software, LLC, Seattle,WA, http://www.ArgusLab.com.
28. Thompson, M. A. (2004). Poster presentation: molecular docking using arguslab: an efficient shape-based search algorithm & the AScore scoring function. Philadelphia: Fall ACS meeting.
29. Hess, B., Kutzner, C., Spoel, D., & Lindahl, E. (2008). J Chem Theory Comput, 4, 435-447.
30. Spoel, D., Lindahl, E., Hess, B., Groenhof, G., Mark, A. E., & Berendsen, H. J. (2005). J Chem Theory Comput, 26, 1701-1718.
31. Meagher, K. L., & Carlson, H. A. (2005). Proteins: Structural Functions Bioinformatics, 58, 119-125.
32. Darden, T., Perera, L., Li, L., & Pedersen, L. (1999). Structure, 7, 55-60.
33. Van Gunsteren, W. F., & Berendsen, H. J. (1977). Molecular Physics, 34, 1311-1327.
34. Wallace, A. C., Laskowski, R. A., & Thornton, J. M. (1995). Protein Engineering, 8, 127-134.
35. Colman, P. M., Varghese, J. N., & Laver, W. G. (1983). Nature, 303, 41-44.
36. Rungrotmongkol, T., Udommaneethanakit, T., Malaisree,M., Nunthaboot, N., Intharathep, P., Sompornpisut, P., & Hannongbua, S. (2009). Biophysical Chemistry, 145, 29-36.
37. Cavasotto, C. N., Kovacs, J. A., & Abagyan, R. A. (2005). Journal of the American Chemical Society, 26, 9632-9640.
38. Teague, S. J. (2003). Nature Reviews. Drug Discovery, 2, 527-541.
39. Durrant, J. D., & McCammon, J. A. (2011). BMC Biology, 9, 71-79.